Multi-center prospective observational study verifying the feasibility of molecular genetic testing for pediatric patients with acute lymphoblastic leukemia. : JCCG ALL-18 study.

Multi-center prospective observational study verifying the feasibility of molecular genetic testing for pediatric patients with acute lymphoblastic leukemia. : JCCG ALL-18 study. - JCCG ALL-18 study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035689

Enrollment

600

Registered

2019-02-01

Start date

2019-01-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute lymphoblastic leukemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Newly diagnosed acute lymphoblastic leukemia 2) Registered to CHM-14 study 3) Age below 25 years old 4) can send samples to central diagnosis 5) informed consent from patients or guardians

Exclusion criteria

Exclusion criteria: Judged to be inappropriate for registration by investigators

Design outcomes

Primary

Measure	Time frame
3 year event free survival and 3 year overall survival	—

Countries

Japan

Contacts

Public ContactKatsuyoshi Koh

Saitama Children's Medical Center Department of Hematology/Oncology

kkoh-tokyo@umin.ac.jp048-601-2200

Outcome results